Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CFO "UN"Resigns. Accepted unresignation by BOD. this is good news
News, VCEL added to Russell 3000 June 22, 2018.
Onward and Upward...……..
COGT back to $3 this am
I didn't actually mean the insiders bought at 9, the SEC filings were reported as news at 9pm Thurs, I'm sure the buys were made before then at several different prices, just as normal trading occurs.
RDVT $6.10 at close. Up .50 cents in the last hour.
Also, new Fluent insiders just purchased approx 1.5 million shares of COGT Thurs evening 9pm.
Noticed buys today of .01 and.0194, something happening?
Must be end of day , nothing here as of 2:38pm, Trading begins tomorrow I suppose. Level II shows bid $5 ask $30. Who knows what will happen.
Also, Dragonchain, and Fluent with Red Violet make up the value here. Certainly much more than current $3.50 COGT.
Trading certainly looks like accumulation for the past two weeks.
Saavy investors methinks.
GLA
Its Red Violet at 7.5 to 1.
Let then eat cake he said............
Mitk: Ladenburg Thalmann initiates as a buy
COGT news today, Early spin-off dividend of one share of Red Violet for 4 to 5 shares in COGT . Bonus in effect, drop in share price might have been big investors gathering shares for spin-off. My guess, should have bought as much as I could at 3.05.
GLA
Piper Jaffray affims buy rating at 7 dollars for VCEL 6 am ..........
"Based on the expanding surgeon customer base and the increasing volume of MACI biopsies and implants, we believe that demand for MACI will far exceed that for Carticel. Given the MACI launch momentum and expanded patient access, we have initiated another sales force expansion in order to drive continued strong revenue growth in 2018 and beyond."
news: RADA Electronic Industries Announces Q1 2017 Results: YoY Revenue Growth of 91%; Return to Profitability, .02 earnings vs (.23) last yr. Revenue expected $20 million this year
up pre market
vcel on new 5 cent trade increment plan
RADA shareholders approves a 2:1 RS today, eff date?
RADA Electronic Industries will provide its CHR-based RPS-10 radar system to Artis in the U.S.
Huge deal........
IAI signed a deal for the leasing of UAV systems, and RADA expects orders for its parts are embedded predecessors
RADA may see tens of millions of shekels a transaction of IAI. The latter signed last week with the German army on a huge deal of 600 million euros for the leasing of five systems, UAVs (unmanned aerial vehicle) sample Heron TP, Eitan called Israel. UAVs will be handed over to Germany and will become operational by 2018.
news......
RADA Avionics Products Integrated In IAI Heron TP
SAN DIEGO, June 14, 2016 (GLOBE NEWSWIRE) -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that it has been issued U.S. Patents No. 9,292,737 and 9,324,073 by the U.S. Patent and Trademark Office. Mitek now has 26 patents issued and 17 patents pending. These latest patents cover Mitek's technology for automatically identifying different types of remittance and invoice documents facilitating the extraction of data from an image captured with a mobile device. This innovation, which is integral to Commercial Mobile Deposit Capture(R) , enables employees to capture invoices and checks at point of presentment, making processing a payment accepted from a customer in the field easier. These patents illustrate Mitek's technological advantages over conventional systems which require foreknowledge of document layouts and labor-intensive setup processes in order to extract data from these documents.
interesting............
Needham & Company analyst Chad Messer reiterated a Buy rating and $12 price target on Vericel Corporation (NASDAQ: VCEL) after Phase IIb ixCELL-DCM data presented today at the American College of Cardiology demonstrated a robust reduction in composite clinical cardiac events for ixmyelocel-T versus placebo. Unfortunately data on the secondary endpoints, including NYHA and 6MWT, were confounding with no meaningful differences between the groups, Messer comments. The lack of difference appears to be driven by a troubling placebo effect.
of course..........
the shorts should ask "Why would they host a webcast the day after the results are announced to discuss BAD results" They wouldn't
Going up big today to thinkers.
Well........
What would earnings from Dec 31 2015 have to do with the current situation. A lot has happened since Jan. The stock price should reflect the current situation and future.
Many unknowing and shorts try to take advantage of old news.
I didnt really see where posters noted that earnings from 2015 never had a chance to reflect anything current.
Ths price will move based on the conference call and future potential, earnings never were relevant here.
Vericel Submits Biologics License Application to the FDA for MACI for the Treatment of Cartilage Defects in the Knee
CAMBRIDGE, Mass., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for MACIâ„¢ (matrix applied characterized autologous cultured chondrocytes), the company's investigational autologous cellular product intended for the treatment of symptomatic cartilage defects of the knee in adult patients.
"The BLA submission for MACI represents an important step toward our goal of providing a new treatment option for the repair of symptomatic cartilage defects of the knee in adult patients," said David Recker, MD, chief medical officer of Vericel. "We look forward to continuing to work closely with the FDA during the BLA filing and review process for MACI in the United States."
News.........
Revenue increase 31% this qtr.
EPS Net loss 16 cts vs 94 cts.
Stock up pre market
NETANYA, Israel, July 28, 2015 (GLOBE NEWSWIRE) -- RADA Electronic Industries of Netanya, Israel (NASDAQ:RADA) announces the purchase of a Multi-Mission Hemispheric Radar (MHR), by a branch of the US military for testing and evaluation of its capabilities. This purchase, which is the first by this branch of the US military, follows previous purchases of MHRs by leading US integrators and end users for similar purposes. The MHR will be delivered before the end of 2015.
The MHR -- an S-Band, software-defined, Pulse-Doppler, active electronically scanned array radar -- has sophisticated beam forming capabilities and advanced signal processing, provides multiple missions on each radar platform, and offers unprecedented performance-to-price ratio. It is compact and mobile, delivering ideal organic, tactical surveillance solutions for force and border protection applications such as counter rockets and mortars, counter unmanned aerial systems, ground moving target indicator and air surveillance.
Zvi Alon, RADA's CEO, remarked, "We are very pleased with the growing interest in our radars by the US market, which we believe will be one of the most important markets for our radar technology."
NETANYA, Israel, July 1, 2015 (GLOBE NEWSWIRE) -- RADA Electronic Industries of Netanya, Israel (Nasdaq:RADA) announced today that it was awarded a contract from a leading Israeli defense contractor to upgrade a previously designed UAV (unmanned aerial vehicle) avionics unit and to supply additional production units. The total order value is $1.5 million with deliveries expected during the next 24 months.
During the last 10 years, UAV avionics have been one of the established areas of expertise at RADA, and the company is active in this market both in Israel and overseas.
For this new order, RADA will upgrade and modify the design of a previously developed unit, qualify the upgraded unit to the UAV environment and supply production units.
Zvi Alon, RADA's CEO, commented: "This contract evidences the long-term recognition by a leading defense contractor of our avionics design and production capabilities, and we expect to maintain our presence in this advanced avionics market."
Matt Margolis at Seeking Alpha says $100 to possibly $125 per share valuation
RADA Electronic Industries and DRS Technologies Team for the North American AESA Radar Market............
NETANYA, Israel, March 31, 2015 (GLOBE NEWSWIRE) -- RADA Electronic Industries of Netanya, Israel announced today that it has signed a strategic teaming agreement with DRS Technologies, Inc. to bring RADA's tactical active electronically scanned array (AESA) radar technology into the North American market.
Under this agreement, DRS will market, sell, produce and support tactical AESA radars as part of its tactical radar portfolio. The combination of RADA's technology along with DRS market presence, customer awareness, engineering, and production capabilities is expected to produce significant interest in the North American defense industry market.
"We are excited to be able to offer our customers RADA's proven technology that offers enhanced hostile-fire protection for our troops," said Joseph Matteoni, Vice President/General Manager of DRS Sustainment Systems, Inc. "RADA's cost-effective detection technology will allow DRS to continue its legacy of meeting the challenging needs of our growing radar customer base," Matteoni said.
Zvi Alon, RADA's CEO, added: "We value the North American market as the most promising growth market for our tactical radars technology, and are confident that this agreement will facilitate the adoption of this technology and growth of our radars business."
NEWS..........
03/25/2015 7:30 am
Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study of MACI(TM) Implant
Poster Presentation at AAOS Annual Meeting Shows Continued Benefit Over Microfracture Bone Marrow Stimulation Procedure
They are really showing up from everywhere now. Must have been frustrating to see the millions of shares consolidating after yesterdays 80% rise. Doesn't fit the computer program scenario. They really forgot about the low float. The last resort attack is to yell dilution.
The tell for me was the 3 million shares bought today in the first ten minutes all above 2.90 up to 3.25. Then the 600 k shares commited to dropping the price down to 2.75. The joke is the 3 million after that balancing the shorts without scaring anyone between 2.80 and 2.85. I think those were the smart ones, probably big investors.
Look , I really dont know where this will go but it is fun watching the short timers hit and run.
GLTA
yes , they would probably be rich right now
yes , they would probably be rich right now
that would be a daytrader not an investor, to each his own .
2.94, currently up .04
true, but the shorters are attacking all over the boards and tweets. The have a basement strategy of finding stocks that jump suddenly and 'automatically" shorting the next day.
It is a published strategy and everyone can invest any way best for them but the smaller investor should be way of these message boards for that reason
GLTA
yes, but that "bottom of page" report has been in RADA articles from the street since nov 2014. Not relevant after todays news. they should update
rada
.........all trades since yesterdays close are above yesterdays close. Beware of the shorters messages, they are trying, there will be some skittish stops taken out but the trend is up 3 mil shares traded UP from yestetrdays close
Street rating
......as quoted was made in Nov 2014. Very different situation I've seen it quoted in several places and it is misleading for today, but
The street should update this today quickly or play into shooters hands
AH
$3.00